The Global Biodegradable Materials for Vascular Stents Market was valued at USD 285.67 Million in 2023 and is projected to reach USD 892.34 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 17.6% during the forecast period (2024–2030). This growth is being driven by rising incidences of cardiovascular diseases, demand for less invasive treatments, and the accelerating adoption of bioresorbable stents that eliminate permanent implants across coronary and peripheral applications.

The USA market for Global Biodegradable Materials for Vascular Stents is estimated to increase from USD 85.20 Million in 2023 to reach USD 265.40 Million by 2030, at a CAGR of 17.5% during the forecast period of 2023 through 2030.

The China market for Global Biodegradable Materials for Vascular Stents is estimated to increase from USD 45.60 Million in 2023 to reach USD 180.20 Million by 2030, at a CAGR of 21.2% during the forecast period of 2023 through 2030.

The Europe market for Global Biodegradable Materials for Vascular Stents is estimated to increase from USD 60.30 Million in 2023 to reach USD 210.10 Million by 2030, at a CAGR of 19.1% during the forecast period of 2023 through 2030.

As the interventional cardiology field shifts toward temporary scaffolds that promote vessel healing and avoid lifelong anticoagulation risks, the focus turns to innovative material developers pioneering biocompatible polymers and alloys. In this blog, we profile the Top 10 Companies in the Global Biodegradable Materials for Vascular Stents Industry—a blend of medtech leaders, polymer specialists, and alloy innovators redefining temporary vascular support.

---

🔟 1. Shenzhen Salubris Pharmaceuticals

Headquarters: Shenzhen, China
Key Offering: PLLA-based bioresorbable stents, magnesium alloy scaffolds

Shenzhen Salubris Pharmaceuticals stands out as a key player in Asia’s emerging medtech scene, developing advanced biodegradable materials for vascular applications. Their portfolio supports coronary interventions with materials engineered for controlled degradation, serving hospitals and clinics across China and expanding into Southeast Asia.

Innovation Highlights:

• Custom PLLA formulations for optimal radial strength
• Clinical trials advancing magnesium scaffolds
• Focus on reducing late thrombosis risks

Download FREE Sample Report: Global Biodegradable Materials for Vascular Stents Market – View in Detailed Research Report

---

9️⃣ 2. Shanghai Bio-heart Biological Technology

Headquarters: Shanghai, China
Key Offering: PLGA copolymers, bioresorbable vascular scaffolds

Shanghai Bio-heart excels in biotechnology, supplying PLGA materials tailored for stents that degrade predictably within 2-3 years. Their innovations address mechanical limitations of earlier generations, gaining traction in high-volume Asian markets where cardiovascular procedures are surging.

Innovation Highlights:

• R&D in tunable degradation profiles
• Partnerships with local stent manufacturers
• Preclinical data on vessel remodeling

---

8️⃣ 3. Beijing Advanced Medical Technologies Co

Headquarters: Beijing, China
Key Offering: Magnesium alloys, PLLA composites

Beijing Advanced Medical Technologies contributes to China’s self-reliance in medtech by producing high-purity magnesium alloys for stents. These materials offer superior biocompatibility, supporting rapid endothelialization while fully resorbing, ideal for younger patients avoiding metallic implants.

Innovation Highlights:

• Corrosion-resistant Mg-Re alloys
• Integration with drug-eluting platforms
• Regulatory approvals in domestic markets

---

7️⃣ 4. LifeTech Scientific Corporation

Headquarters: Shenzhen, China
Key Offering: Bioresorbable polymers, vascular stents

LifeTech Scientific Corporation leverages its expertise in interventional devices to advance biodegradable materials, focusing on PLLA for coronary and peripheral uses. Their scalable production meets growing demand from emerging economies with high stent implantation rates.

Innovation Highlights:

• Next-gen PLGA for biliary applications
• Collaborations for clinical validation
• Expansion into tracheal stents

Download FREE Sample Report: Global Biodegradable Materials for Vascular Stents Market – View in Detailed Research Report

---

6️⃣ 5. MicroPort Scientific Corporation

Headquarters: Shanghai, China
Key Offering: Firehawk PLLA stents, bioresorbable materials

MicroPort Scientific leads with its Firehawk platform, utilizing thin-strut PLLA materials that balance strength and resorption. Operating globally, they supply materials enhancing sirolimus elution, reducing restenosis in complex lesions.

Innovation Highlights:

• Hybrid polymer-alloy developments
• International clinical studies
• Supply chain for urethral stents

---

5️⃣ 6. BIOHUAAN

Headquarters: Hangzhou, China
Key Offering: PLLA scaffolds, magnesium-based stents

BIOHUAAN specializes in fully bioresorbable scaffolds using proprietary PLLA formulations, approved for coronary use in China. Their materials promote natural vessel function post-resorption, positioning them strongly in the Asia-Pacific region.

Innovation Highlights:

• Advanced manufacturing for uniformity
• Degradation kinetics optimization
• Trials for peripheral indications

---

4️⃣ 7. Lepu Medical

Headquarters: Beijing, China
Key Offering: Bioresorbable stents, polymer materials

Lepu Medical drives innovation with its Leo BRS, crafted from high-molecular-weight PLLA for sustained radial force. As a major exporter, they influence global standards in biodegradable tech for vascular patency.

Innovation Highlights:

• Drug-polymer synergies
• Expansion to biliary and urethral
• Robust R&D pipeline

---

3️⃣ 8. Biotronik (Magmaris)

Headquarters: Bülach, Switzerland
Key Offering: Magmaris magnesium scaffold, resorbable alloys

Biotronik’s Magmaris represents a breakthrough in magnesium technology, resorbing in 12 months while providing mechanical support. Widely studied in Europe, it serves complex PCI cases with low recoil and thrombosis rates.

Innovation Highlights:

• SIROTM coating for bioresorption
• BIOSOLVE trials data
• Adaptations for non-coronary uses

---

2️⃣ 9. Elixir Medical Corporation

Headquarters: Milpitas, California, USA
Key Offering: Mirage PLLA scaffold, dynamic bioresorption

Elixir Medical’s Mirage stent features a unique PLLA design with gradient degradation, mimicking vessel motion. Backed by strong U.S. trials, it targets acute recoil prevention and long-term patency.

Innovation Highlights:

• Mechanical performance simulation
• Global partnerships for adoption
• Focus on high-risk patients

---

1️⃣ 10. Abbott

Headquarters: Abbott Park, Illinois, USA
Key Offering: Absorb BVS (PLLA), next-gen bioresorbable platforms

Abbott pioneered commercial bioresorbable stents with Absorb, leveraging PLLA for full resorption by year three. Despite past challenges, their ongoing R&D positions them as a leader in material refinement for safer outcomes.

Innovation Highlights:

• Thinner struts evolution
• Extensive clinical evidence base
• Pipeline for magnesium hybrids

Read Full Report: Global Biodegradable Materials for Vascular Stents Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Biodegradable Materials for Vascular Stents Is Resorbable and Restorative

The biodegradable materials market for vascular stents is experiencing rapid evolution. Although metallic stents hold volume share, investments surge in polymers like PLLA, PLGA, PCL, and magnesium alloys that vanish post-healing, minimizing complications.

📈 Key Trends Shaping the Market:

• Expansion of PLLA and Mg alloy capacities in Asia, Europe, and North America
• Regulatory approvals pushing 20-30% adoption by 2030
• AI-driven material design and degradation modeling
• Medtech alliances for hybrid drug-device combos

Read Full Report: Global Biodegradable Materials for Vascular Stents Market – View in Detailed Research Report

The companies profiled are not only supporting vessel patency—they’re leading the bioresorbable revolution in cardiology.